Breast Cancer
  • Featured content
    Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
  • Featured content
    In this downloadable slideset, Margaret Callahan, MD, PhD; Shirish Gadgeel, MD; Ryan T. Merrell, MD; Bradley J. Monk, MD, FACS, FACOG; and Joyce O’Shaughnessy, MD, review important clinical presentations across multiple cancers from the 2016 oncology meeting in Copenhagen.
    Date Posted: 12/12/2016
  • Featured content
    Use this Interactive Decision Support Tool to enter your patient’s specific presentation characteristics then compare your choice of therapy with expert recommendations from Kimberly L. Blackwell, MD; Sara Hurvitz, MD, FACP; Mohammad Jahanzeb, MD, FACP; Kathy D. Miller, MD; and Nicholas J. Robert, MD.
    Date Posted: 12/9/2016
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, each provide an analysis of key presentations on cancer immunotherapy from the 2016 clinical oncology meeting in Chicago.
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, provide an analysis of key presentations on cancer immunotherapy from the 2016 Clinical Oncology meeting in Chicago.
    Date Posted: 9/19/2016
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 128 Shown
10 of 128 Shown
Show 10 More
Loading...